Lifestyle Stress Study, 2007
Abstract: WGP 3-6 Reduces Immune Suppression and Improves Mood State in Stressed Subjects.
Presentation: American College of Nutrition Annual Meeting, Sept 2007
Publication: Nutrition Today, pending
Summary:
Highly stressed individuals participating in an independent clinical study reported a significant increase in their general health after taking BetaRight WGP®, a natural compound that activates key immune cells.
A total of 150 people (45 men and 105 women ages 18-65) categorized as leading highly stressful lives completed the double-blind, placebo-controlled study.; The participants received either BetaRight WGP or a placebo daily for four weeks. The study measured both stress-related incidence of upper respiratory tract infection symptoms (i.e. cold, flu) and psychological well-being, including levels of vigor, tension, mental clarity and fatigue.
High-stress subjects taking 250 mg of BetaRight WGP daily reported a 41% increase in general health when compared with the placebo group over the four-week study period. (All reported data is statistically significant at the p<0.05 level.) In comparison with the placebo group, the BetaRight WGP group reported a:
- 42% increase in vigor
- 38% reduction in fatigue
- 19% reduction in tension
- 15% reduction in stress-induced confusion
The BetaRight WGP group also reported fewer symptoms associated with upper respiratory tract infections, including nasal congestion, runny nose, sore throat, sneezing, cough, fatigue, headache, general malaise and body aches.; After four weeks of treatment, 28% of the placebo group reported URTI symptoms, compared with 8% in the groups taking BetaRight WGP.
Study Design
Subjects were selected for the study using a 15-question survey that assessed individual levels of perceived stress. This screening method was successfully used in six prior clinical studies. The subjects were randomly administered either BetaRight wgp or a placebo for four weeks.
The physical health of the study subjects was evaluated based on reported incidence of URTI-related symptoms. Subjects were asked to score their health during the supplementation using a 1-to-10 scale (1=worse, 10-better) and similarly rate their overall health status.
The psychological well-being of the study participants was measured using a Profile of Mood States (POMS) questionnaire. POMS is a validated psychometric test that measures six primary mood states: tension, depression, anger, fatigue, vigor and confusion. The POMS profile method has been employed in more than 2,900 health studies.